Publications
Publications
Show Results For
- All HBS Web
(402)
- Faculty Publications (228)
- April 2009
- Teaching Note
Amylin Pharmaceuticals: Diabetes and Beyond (TN)
By: Richard G. Hamermesh and Rachel Gordon
Teaching Note for [809011]. View Details
- March 2009
- Teaching Note
Proteus Biomedical: Making Pigs Fly (TN)
Teaching Note for [809051]. View Details
- February 2009
- Teaching Note
Syndexa and Technology Transfer at Harvard University (TN)
Teaching Note for [808073]. View Details
- February 2009
- Teaching Note
Technology Transfer at U.S. Universities (TN)
Teaching Note for [807124]. View Details
Keywords: United States
- December 2008 (Revised October 2013)
- Case
Amylin Pharmaceuticals: Diabetes and Beyond (A)
By: Richard G. Hamermesh and Rachel Gordon
Ginger Graham, CEO of Amylin Pharmaceuticals, joined the company with the expectation of taking the company's signature drug, Symlin, to market. However, unforeseen regulatory challenges have put the approval process in jeopardy. At the same time, the company has a... View Details
- November 2008 (Revised January 2010)
- Case
Stone Finch, Inc.: Young Division, Old Division
By: Richard G. Hamermesh and Elizabeth Collins
CEO Jim Billings wants to attract energetic, entrepreneurial talent to Stone Finch, Inc., which comprises an older division that fabricates products like piping and tanks for water and wastewater processing plants, and a much newer division that develops biochemical... View Details
Keywords: Organizational Behavior; Human Resource Management; Motivation; Business Growth; Motivation and Incentives; Leadership; Business Subsidiaries; Innovation Strategy; Resource Allocation; Organizational Structure; Organizational Culture; Retention; Operations; Recruitment; Integration; Business Growth and Maturation; Mergers and Acquisitions; Growth and Development Strategy; Manufacturing Industry
- November 2008 (Revised January 2010)
- Teaching Note
Stone Finch, Inc.: Young Division, Old Division (Brief Case)
By: Richard G. Hamermesh and Elizabeth Collins
Teaching Note for 3214 View Details
- November 2008 (Revised January 2010)
- Supplement
Stone Finch, Inc.: Young Division, Old Division, Spreadsheet Supplement for Instructors (Brief Case)
By: Richard G. Hamermesh and Elizabeth Collins
- November 2008 (Revised January 2010)
- Supplement
Stone Finch, Inc.: Young Division, Old Division, Student Spreadsheet (Brief Case)
By: Richard G. Hamermesh and Elizabeth Collins
- May 2008 (Revised June 2009)
- Case
House of Tata: Acquiring a Global Footprint
By: Tarun Khanna, Krishna G. Palepu and Richard Bullock
Chronicles the globalization of the Tata Group, one of India's largest business groups. Since 2000, many Tata Group operating companies have aggressively built international businesses, particularly through overseas acquisitions. After describing the globalization... View Details
- April 2008
- Supplement
ProfitLogic (CW)
By: Lynda M. Applegate, Richard G. Hamermesh and Michael J. Roberts
This interactive spreadsheet accompanies the ProfitLogic case (#802-110) to enable analysis of the cash flow implications of three business models that the company is considering. Students are able to change key assumptions and see the impact on cash flow. View Details
- February 2008
- Teaching Note
DermaCare: Zapping Zits Directly (TN)
Teaching Note for [808064]. View Details
- February 2008 (Revised January 2010)
- Teaching Note
Calloway Laboratory: Pee for Profit (TN)
Teaching Note for [807-040]. View Details
Keywords: Profit
- January 2008 (Revised January 2009)
- Teaching Note
Cynthia Fisher and the Rearing of ViaCell (TN)
By: Robert F. Higgins, Richard G. Hamermesh and Erin Seefeld
Teaching Note for [806002]. View Details
Keywords: Management
- October 2007
- Case
Blue River Capital
By: Krishna G. Palepu, Tarun Khanna and Richard Bullock
Examines the strategy and experience of Indian private equity firm Blue River Capital. Blue River was established in 2005 to invest primarily in middle market, particularly family-run, businesses in India. Blue River caters to this niche as an active investor,... View Details
- October 2007
- Article
Realizing the Promise of Personalized Medicine
By: Mara G. Aspinall and Richard G. Hamermesh
Keywords: Health
- September 2007 (Revised October 2010)
- Case
DermaCare: Zapping Zits Directly
By: Richard G. Hamermesh and Lauren Barley
DermaCare has developed an innovative new product for the treatment of acne that they hope to sell to consumers via direct-response television. The unconventional nature of the product and its distribution has led the company to seek angel financing. The Silicon Valley... View Details
- September 2007 (Revised May 2009)
- Case
Syndexa and Technology Transfer at Harvard University
By: Richard G. Hamermesh and David Kiron
Gokhan Hotamisligil is a star researcher at Harvard School of Public Health who has made groundbreaking discoveries linking fat cells, inflammation, and diabetes. He now wants to form a company to commercialize these discoveries. At the same time, Isaac Kohlberg, the... View Details
- January 2007 (Revised January 2007)
- Background Note
Note on the U.S. Food and Drug Administration
By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller
Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure. View Details